---
figid: PMC9609612__molecules-27-06934-g005
figtitle: Therapeutic Approach of Melatonin against Omicron and Some Other Variants
  of SARS-CoV-2
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Influenza A virus
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Human papillomavirus type 16
- Ebola virus
- Coxsackievirus B3
- Encephalomyocarditis virus
- Venezuelan equine encephalitis virus
- SARS coronavirus LC3
- Rabbit hemorrhagic disease virus
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Mesocricetus auratus
- Musa acuminata
- Ananas comosus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC9609612
filename: molecules-27-06934-g005.jpg
figlink: /pmc/articles/PMC9609612/figure/molecules-27-06934-f005/
number: F5
caption: Hypothetical pathways of melatonin and its metabolites in the treatment of
  COVID-19. (1) Melatonin has a direct free radical scavenging capacity. However,
  this effect is not receptor-dependent. (2) The metabolites of melatonin protect
  the COVID-19-infected cells from oxidative damage byexhibiting strong antioxidant
  effects. (3) Melatonin inhibits protein kinase A (PKA) and Ca2+signaling that could
  modulate gene transcription regulation and antioxidant enzyme concentration. (4)
  Melatonin may lower Ca2+ concentration, which can be influenced to regulate various
  mitogen protein kinases related to the PKC-mediated signaling pathway, i.e., extracellular
  signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK), NF-κB, or PI3/Akt
  pathway activation, and thus modulate gene transcription. (5) Binding with MT1/MT2,
  melatonin activates the Nrf2 signaling pathway and inhibits free radicals, nitric
  oxide synthases, inflammatory cytokines, and oxidative stress.
papertitle: Potential Therapeutic Approach of Melatonin against Omicron and Some Other
  Variants of SARS-CoV-2.
reftext: Rahima Begum, et al. Molecules. 2022 Oct;27(20):6934.
year: '2022'
doi: 10.3390/molecules27206934
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: Omicron variant (B.529) | COVID-19 disease | SARS-CoV-2 | oxidative stress
  | melatonin | antioxidant | therapeutic approach
automl_pathway: 0.9288002
figid_alias: PMC9609612__F5
figtype: Figure
redirect_from: /figures/PMC9609612__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9609612__molecules-27-06934-g005.html
  '@type': Dataset
  description: Hypothetical pathways of melatonin and its metabolites in the treatment
    of COVID-19. (1) Melatonin has a direct free radical scavenging capacity. However,
    this effect is not receptor-dependent. (2) The metabolites of melatonin protect
    the COVID-19-infected cells from oxidative damage byexhibiting strong antioxidant
    effects. (3) Melatonin inhibits protein kinase A (PKA) and Ca2+signaling that
    could modulate gene transcription regulation and antioxidant enzyme concentration.
    (4) Melatonin may lower Ca2+ concentration, which can be influenced to regulate
    various mitogen protein kinases related to the PKC-mediated signaling pathway,
    i.e., extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK),
    NF-κB, or PI3/Akt pathway activation, and thus modulate gene transcription. (5)
    Binding with MT1/MT2, melatonin activates the Nrf2 signaling pathway and inhibits
    free radicals, nitric oxide synthases, inflammatory cytokines, and oxidative stress.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnf
  - Nos2
  - Nfe2l2
  - Cat
  - cac
  - Mip
  - Trpv6
  - Glyat
  - Hmox1
  - Prdx6
  - Gpx1
  - Gpx3
  - Nfkb1
  - Prkaca
  - Akt1
  - Alpha-re
  - TNF
  - NOS2
  - ISYNA1
  - GABPA
  - NFE2L2
  - SOD1
  - SOD2
  - SOD3
  - CAT
  - CRAT
  - GLYAT
  - HMOX1
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - NFKB1
  - PRKACA
  - EXOSC1
  - H3P6
  - AKT1
  - AKT2
  - AKT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Prkcg
  - Th
  - Errfi1
  - so
  - egr
  - Inos
  - Nos
  - Keap1
  - cnc
  - Sod2
  - Sod1
  - Ca-alpha1T
  - ChAT
  - sv
  - Ho
  - PHGPx
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Dif
  - dl
  - Rel
  - Pka-C1
  - ca
  - P13
  - Akt
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - MKP-4
  - p38b
  - rl
---
